CTN NIDA-CTN-0134 Identifying Regional “Hotspots” and Potential Correlates of Precipitated Withdrawal During Buprenorphine Induction in Fentanyl Users Through Prescriber Survey Responses and Patient Urine Drug Test Results (Buprenorphine-Precipitated Withdrawal Hotspots and Correlates)
LaTrice Montgomery, Ph.D. , T. John Winhusen, Ph.D. Jun 03, 2025
CTN NIDA-CTN-0069 Opioid Use Disorder in the Emergency Department (ED-HEALTH)
David A. Fiellin, M.D. , Gail D'Onofrio, M.D., M.S. Mar 21, 2025
CTN NIDA-CTN-0097 Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT)
Adam Bisaga, M.D. , Edward V. Nunes, M.D. Feb 11, 2025
CTN NIDA-CTN-0079 Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT)
John Rotrosen, M.D. , Kathryn Hawk, M.D., M.H.S. , Ryan McCormack, M.D. Nov 04, 2024
CTN NIDA-CTN-0095A2 Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians
Stephanie Hooker, Ph.D., M.P.H. , Rebecca Rossom, M.D., M.S. , A. Lauren Crain, Ph.D. , Gavin Bart, Ph.D., M.D. May 24, 2024
CTN NIDA-CTN-0051A2 Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051
John Rotrosen, M.D. Feb 15, 2024
CTN NIDA-CTN-0075 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder
Li-Tzy Wu, ScD. , Paolo Mannelli, MD Feb 16, 2023
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
John Rotrosen, M.D. Jan 12, 2018
CTN NIDA-CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
Walter Ling, M.D. Apr 24, 2015
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence)
Roger Weiss, M.D. , Jennifer Sharpe Potter, Ph.D. Aug 22, 2014
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence
Walter Ling, M.D. , Roger Weiss, M.D. Jun 22, 2011
CTN NIDA-CTN-0027 Starting Treatment with Agonist Replacement Therapies (START)
Walter Ling, M.D. Jun 06, 2012
CTN NIDA-CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults
George Woody, M.D. Jul 30, 2009
CTN NIDA-CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
Walter Ling, M.D. May 29, 2008
CTN NIDA-CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
Walter Ling, M.D. Jul 26, 2006
CTN NIDA-CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification
Walter Ling, M.D. May 08, 2006
DTMC NIDA-CSP-1018 A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Walter Ling, M.D. , Paul J. Fudala, Ph.D. , Paul Casadonte, M.D. Sep 02, 2015
DTMC NIDA-CSP-1008B A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Peter Bridge, M.D. Dec 04, 2014
DTMC NIDA-CSP-1008A A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Peter Bridge, M.D. , Paul J. Fudala, Ph.D. Dec 04, 2014
DTMC NIDA-CSP-999 A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence
Walter Ling, M.D. , Donald R. Wesson, M.D. , C. James Klett, Ph.D. Sep 02, 2015
